4.5 Article

Checklist for studies of HIV drug resistance prevalence or incidence: rationale and recommended use

期刊

LANCET HIV
卷 10, 期 10, 页码 E684-E689

出版社

ELSEVIER INC
DOI: 10.1016/S2352-3018(23)00173-X

关键词

-

向作者/读者索取更多资源

This study describes a checklist for reporting HIV drug resistance (HIVDR) studies, which aims to enhance transparency, interpretability, comparability, and replicability of HIVDR research. The checklist will assist researchers in preparing research reports and help reviewers and editors assess the completeness of reporting.
HIV drug resistance (HIVDR) is a major challenge to the effectiveness of antiretroviral therapy. Global efforts in addressing HIVDR require clear, transparent, and replicable reporting in HIVDR studies. We describe the rationale and recommended use of a checklist that should be included in reports of HIVDR incidence and prevalence. After preliminary consultations with experts on HIVDR and establishing the need for guidance on HIVDR reporting, we used a sequential, explanatory, mixed methods approach to create the checklist; together with the accompanying articles, the checklist was reviewed by the authors and validated externally. The checklist for studies on HIVDR prevalence or incidence (CEDRIC-HIV) includes 15 recommended items that would enhance transparency and facilitate interpretation, comparability, and replicability of HIVDR studies. CEDRIC-HIV will help authors of HIVDR studies prepare research reports and assist reviewers and editors in assessments of completeness of reporting. The checklist will also facilitate statistical pooling and interpretation of HIVDR data.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据